Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells.
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult.
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
Are Hsp70 protein expression and genetic polymorphism implicated in multiple sclerosis inflammation?
Clinical impact of early brain atrophy in clinically isolated syndromes.
Teriflunomide - a new oral agent for multiple sclerosis treatment.
Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.
Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Falls in people with multiple sclerosis compared with falls in healthy controls.
Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis.
Tai Chi Chuan in Medicine and Health Promotion.
1H-Magnetic Resonance Spectroscopy in diffuse and focal cervical cord lesions in Multiple Sclerosis.
Role of myelin sheath energy metabolism in neurodegenerative diseases.
Regenerative Medicines for Remyelination: From Aspiration to Reality.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
Optic neuritis: From magnocellular to cognitive residual dysfunction.
Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.
Pages
« first
‹ previous
…
504
505
506
507
508
509
510
511
512
…
next ›
last »